{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:51:36Z","timestamp":1776329496596,"version":"3.50.1"},"reference-count":25,"publisher":"Universidad Nacional de C\u00f3rdoba","issue":"2","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Fac Cien Med Univ Nac Cordoba"],"abstract":"<jats:p>Introduction: After the marketing approval of a medicine, pharmacovigilance monitoring must be carried out at an international level and the necessary measures must be adopted to reduce the risk that its use may present. Restrictive measures are not taken with the same speed in all countries and there are differences in withdrawal patterns.\nObjectives: Identify medicines that have been withdrawn from marketing for safety reasons in countries with health reference agencies (SRA), between January 2014 and June 2023. Establish if these medicines were withdrawn from the market in Argentina.\nMethodology: Search for information on SRA, National Administration of Food Drugs and Medical Technology (ANMAT) websites and secondary sources. For each medication withdrawn by any SRA, the validity of the marketing certificate and regulatory actions in Argentina were verified.\nResults: In countries with SRA health agencies, 31 medications were withdrawn for safety reasons. Of these, in Argentina, 7 were identified with a valid marketing certificate, another 7 were withdrawn from the market mostly by the manufacturing laboratories, 14 were never marketed and no data was obtained for 3.\nConclusion: In Argentina, medications were identified that were withdrawn from other countries and continue to have a valid marketing certificate. The number of regulatory actions related to safety aspects in our country was lower than those of countries with SRA. It is necessary to strengthen the pharmacovigilance system, and for ANMAT to apply measures that reduce the risk associated with the use of the questioned medications.<\/jats:p>","DOI":"10.31053\/1853.0605.v82.n2.46049","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:16:54Z","timestamp":1750954614000},"page":"253-270","source":"Crossref","is-referenced-by-count":1,"title":["Medicamentos retirados en otros pa\u00edses por problemas de seguridad, entre 2014 y 2023, y su permanencia en el mercado argentino","Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market","Medicamentos retirados de outros pa\u00edses por problemas de seguran\u00e7a, entre 2014 e 2023, e sua perman\u00eancia no mercado argentino"],"prefix":"10.31053","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-2688","authenticated-orcid":false,"given":"Mariana","family":"Caffaratti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-5866","authenticated-orcid":false,"given":"Mart\u00edn","family":"Ca\u00f1\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Eduardo","family":"Domosbian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Giraudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2030-0890","authenticated-orcid":false,"given":"Susana N\u00fa\u00f1ez","family":"N\u00fa\u00f1ez Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-0523","authenticated-orcid":false,"given":"Mar\u00eda Teresa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-6486","authenticated-orcid":false,"given":"Mar\u00eda Luz","family":"Traverso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Uema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12333","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Institute of Medicine (US) Committee on Quality of Health Care in America. To Err is Human: Building a Safer Health System. Kohn LT, Corrigan JM, Donaldson MS, editors. Washington (DC): National Academies Press (US); 2000. doi: 10.17226\/9728.","DOI":"10.17226\/9728"},{"key":"ref1","unstructured":"2. World Health Organization. Patient Safety. Key facts. WHO; 2019. Disponible en: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/patient-safety."},{"key":"ref2","unstructured":"3. Organizaci\u00f3n Panamericana de la Salud. Buenas Pr\u00e1cticas de Farmacovigilancia para las Am\u00e9ricas. Red PARF Documento T\u00e9cnico No. 5 Washington D.C. 2011. Disponible en: https:\/\/www.paho.org\/sites\/default\/files\/Technical-Doc-5-web.pdf"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf. 2005;28(10):851-70. doi: 10.2165\/00002018-200528100-00003.","DOI":"10.2165\/00002018-200528100-00003"},{"key":"ref4","unstructured":"5. Papale RM. Schiaffino S. Manual de Buenas Pr\u00e1cticas de Farmacovigilancia. Edici\u00f3n Latinoam\u00e9rica. Ciudad Aut\u00f3noma de Buenos Aires: Ediciones Farmacol\u00f3gicas; 2018. Disponible en: https:\/\/www.argentina.gob.ar\/sites\/default\/files\/manual_de_fvg_edicion_latam.pdf"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Khalil H, Huang C. Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res. 2020 Jan 6;20(1):5. doi: 10.1186\/s12913-019-4651-7.","DOI":"10.1186\/s12913-019-4651-7"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Onakpoya IJ, Heneghan CJ, Aronson JK. Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis. BMC Med. 2015;13: 26. doi:10.1186\/s12916-014-0262-7.","DOI":"10.1186\/s12916-014-0262-7"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016 Feb 4;14: 10. doi: 10.1186\/s12916-016-0553-2.","DOI":"10.1186\/s12916-016-0553-2"},{"key":"ref8","unstructured":"9. World Health Organization, Prequalification of Medical Products. Regulatory Agencies. WHO; 2023. Disponible en: https:\/\/extranet.who.int\/prequal\/medicines\/regulatory-agencies."},{"key":"ref9","unstructured":"10. Poder Ejecutivo Nacional. Argentina. Decreto 150\/1992. Normas para el registro, elaboraci\u00f3n, fraccionamiento, prescripci\u00f3n, expendio, comercializaci\u00f3n, exportaci\u00f3n e importaci\u00f3n de medicamentos. 1992. Disponible en: https:\/\/www.argentina.gob.ar\/normativa\/nacional\/decreto-150-1992-8196\/texto."},{"key":"ref10","unstructured":"11. Honorable Congreso de la Naci\u00f3n Argentina. Ley 16.463 de medicamentos. 1945. Disponible en: https:\/\/www.argentina.gob.ar\/normativa\/nacional\/ley-16463-20414\/texto."},{"key":"ref11","unstructured":"12. Ministerio de Econom\u00eda y Obras y Servicios P\u00fablicos y Ministerio de Salud y Acci\u00f3n Social. Resoluci\u00f3n Conjunta 988\/92 y 748\/92. 1992. Disponible en: https:\/\/www.argentina.gob.ar\/normativa\/nacional\/resoluci%C3%B3n-988-1992-89011\/actualizacion"},{"key":"ref12","unstructured":"13. Poder Ejecutivo Nacional. Argentina. Decreto 1490\/92. 1992. Disponible en: https:\/\/www.argentina.gob.ar\/normativa\/nacional\/decreto-1490-1992-9909\/texto."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Buschiazzo H, Dorati C, Iusef Venturini N, Ca\u00f1as M, Urtasun MA, Marin GH, Prozzi GR, Rivadulla PA, Trionfetti M, Mordujovich Buschiazzo P. Medicamentos retirados en otros pa\u00edses por problemas de seguridad: \u00bfDeben seguir presentes en el mercado farmac\u00e9utico argentino? Rev Fac Cien Med Univ Nac Cordoba. 2022 Sep 16;79(3):241-247. doi: 10.31053\/1853.0605.v79.n3.35443.","DOI":"10.31053\/1853.0605.v79.n3.35443"},{"key":"ref14","unstructured":"15. World Health Organization. List of transitional WLAs (in alphabetical order). WHO; 2022. Disponible en: https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/regulatory-updates\/wla\/list-of-transitional-wlas.pdf."},{"key":"ref15","unstructured":"16. Anido F, Lepetit-Chella N. C\u00f3mo encontramos diez principios activos prohibidos por peligrosos en algunos pa\u00edses y a la venta en otros. El Mundo. 2017 enero 16. Salud Disponible en: https:\/\/www.elmundo.es\/salud\/2017\/01\/16\/57cd7ced22601d51538b45ac.html."},{"key":"ref16","unstructured":"17. Telithromycin: a welcome market withdrawal. Prescrire Int. 2018;27(196):210. Dsiponible en: https:\/\/english.prescrire.org\/en\/81\/168\/55234\/0\/NewsDetails.aspx."},{"key":"ref17","unstructured":"18. Zosia Chustecka. AstraZeneca Withdraws Drug for Hairy Cell Leukemia from US Market. Medscape. 2023 Jan 13 [acceso: 2023 septiembre 25]. Disponible en: https:\/\/www.medscape.com\/viewarticle\/986938_print."},{"key":"ref18","unstructured":"19. Argentina. Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica. Disposici\u00f3n ANMAT 3416\/2020. 2020, mayo 22 [acceso 2023 julio 18]. Disponible en: https:\/\/www.argentina.gob.ar\/normativa\/nacional\/disposici%C3%B3n-3416-2020-338194\/texto."},{"key":"ref19","unstructured":"20. Argentina. Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica. Disposici\u00f3n N\u00b0 DI-2023-1613-APN-ANMAT#MS. 2023, febrero 27. [acceso 2023 julio 27]. Disponible en: https:\/\/boletin.anmat.gob.ar\/febrero_2023\/Dispo_1613-23.pdf."},{"key":"ref20","unstructured":"21. Manso G, Hidalgo A, Carvajal A, De Abajo F. Los primeros 25 a\u00f1os del Sistema Espa\u00f1ol de Farmacovigilancia de Medicamentos de uso humano. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS), 2010."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Aronson JK. Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems. Therapie. 2017 Oct;72(5):555-561. doi: 10.1016\/j.therap.2017.02.005.","DOI":"10.1016\/j.therap.2017.02.005"},{"key":"ref22","unstructured":"23. Salud y F\u00e1rmacos [tr]. Retirada del mercado debido a los efectos adversos: frecuente pero muchas veces tard\u00eda. En: Revue Prescrire 2017; 37 (402): 299-301. Bolet\u00edn F\u00e1rmacos. 2020 dic 4. [acceso 2023 julio 14]. Disponible en: https:\/\/www.saludyfarmacos.org\/lang\/en\/boletin-farmacos\/boletines\/nov201701\/04_retirada\/#."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-96. doi: 10.2165\/00002018-200629050-00003.","DOI":"10.2165\/00002018-200629050-00003"},{"key":"ref24","unstructured":"25. Argentina. Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica. Departamento de Farmacovigilancia. Informe Anual 2017. Buenos Aires: ANMAT; 2017. Disponible en: https:\/\/www.argentina.gob.ar\/sites\/default\/files\/farmacovigilancia-informe_2017.pdf."}],"container-title":["Revista de la Facultad de Ciencias M\u00e9dicas de C\u00f3rdoba"],"original-title":[],"link":[{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/46049\/49096","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/46049\/49097","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/46049\/49097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:53:50Z","timestamp":1750956830000},"score":1,"resource":{"primary":{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/view\/46049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,26]]}},"URL":"https:\/\/doi.org\/10.31053\/1853.0605.v82.n2.46049","relation":{},"ISSN":["1853-0605","0014-6722"],"issn-type":[{"value":"1853-0605","type":"electronic"},{"value":"0014-6722","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}